Companies /Consumer Cyclical

Green Brick Partners Inc

NYSE: GRBK Residential Construction
$60.86
▼ $1.67 (−2.67%) today
Markets closed · 8:04pm ET

GRBK at a Glance

Valuation
Market cap
$2.7B
P/E ratio
10.1
Profitability
Revenue (TTM)
$1.9B
Profit margin
14.2%
EPS (TTM)
$6.22
Price
52-week range
$59 – $83
Street target
$62.00

Headquartered in Plano, TX Fiscal year ends December NYSE: GRBK greenbrickpartners.com

About Green Brick Partners

Green Brick Partners, Inc. (NYSE: GRBK) is a diversified homebuilding and land development company operating in Texas, Georgia and Florida. It describes itself as the third largest homebuilder in Dallas-Fort Worth.

It owns five subsidiary homebuilders in Texas: CB JENI Homes, Normandy Homes, Southgate Homes, Trophy Signature Homes and a 90% interest in Centre Living Homes. It also holds a 50% interest in The Providence Group in Atlanta and an 80% interest in GHO Homes in Port St. Lucie, Florida.

The company covers the full homebuilding process: land acquisition and development, entitlements, design, construction, marketing and sales for residential neighborhoods and master-planned communities. Its strategy centers on owning and self-developing land in infill and infill-adjacent submarkets, with 40,869 lots owned as of September 30, 2026, mostly in its Central (Texas) region. The Trophy Signature Homes brand is a key growth driver in its core Texas markets.

It reports three segments: Residential Units, Land and Lots, and Financial Services. Financial services include Green Brick Title, Green Brick Mortgage and Green Brick Insurance. The company is expanding mortgage capture among its homebuyers to add an additional earnings stream. Updated

GRBK Coverage

Frequently Asked Questions

What does Green Brick Partners do?

Green Brick Partners, Inc. (NYSE: GRBK) is a diversified homebuilding and land development company operating in Texas, Georgia and Florida. It describes itself as the third largest homebuilder in Dallas-Fort Worth.

What is the GRBK stock price target?

The Wall Street consensus 12-month price target for GRBK is $62.00.